TSE:2413Healthcare Services
Does M3 (TSE:2413) Prioritize Scale Over Profitability As New Guidance And Stock Options Emerge?
M3, Inc. reported past first-quarter 2026 results showing sales of ¥90,105 million versus ¥86,200 million a year earlier, while net income and earnings per share decreased year on year.
The company also issued new earnings guidance for the half year to September 30, 2026 and full year to March 31, 2027, alongside a board move to consider granting stock options, giving investors fresh insight into both operational expectations and management incentives.
Next, we will examine how M3’s higher...